Biopharm ink New Year service deals in drive to enter clinic
Biopharm companies have inked a raft of contract service deals at the start of 2012 in efforts to push compounds into the clinic.
Archives for January 5, 2012
Alnylam hails RNAi delivery tech as future of biz after PhI results
Phase I data shows Alnylam a “very potent” RNAi delivery platform that can be the foundation of its future, the company’s CEO said.
US FDA's 2011 guidance documents round-up
The US Food and Drug Administration (FDA) will soon start asking drugmakers to play a greater role in guideline development. Before that process begins in-Pharmatechnologist.com takes a look at the documents published by the agency in 2011.
Accelrys moves into Pharma QA/QC with VelQuest acquisition
R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.